These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23998932)

  • 1. miRNA-21 inhibition enhances RANTES and IP-10 release in MCF-7 via PIAS3 and STAT3 signalling and causes increased lymphocyte migration.
    Wang Z; Han J; Cui Y; Zhou X; Fan K
    Biochem Biophys Res Commun; 2013 Sep; 439(3):384-9. PubMed ID: 23998932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics.
    Xiong Q; Zhong Q; Zhang J; Yang M; Li C; Zheng P; Bi LJ; Ge F
    J Proteome Res; 2012 Apr; 11(4):2078-90. PubMed ID: 22316494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer.
    Jiang M; Zhang W; Zhang R; Liu P; Ye Y; Yu W; Guo X; Yu J
    Oncogene; 2020 Jun; 39(24):4681-4694. PubMed ID: 32398867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response.
    Yagil Z; Nechushtan H; Kay G; Yang CM; Kemeny DM; Razin E
    Trends Immunol; 2010 May; 31(5):199-204. PubMed ID: 20181527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Formylchromone inhibits proliferation and induces apoptosis of multiple myeloma cells by abrogating STAT3 signaling through the induction of PIAS3.
    Ko JH; Ho Baek S; Nam D; Chung WS; Lee SG; Lee J; Mo Yang W; Um JY; Seok Ahn K
    Immunopharmacol Immunotoxicol; 2016 Oct; 38(5):334-43. PubMed ID: 27324722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positive feedback loop between miR-181b and STAT3 that affects Warburg effect in colon cancer via regulating PIAS3 expression.
    Pan X; Feng J; Zhu Z; Yao L; Ma S; Hao B; Zhang G
    J Cell Mol Med; 2018 Oct; 22(10):5040-5049. PubMed ID: 30054984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma.
    He T; McColl K; Sakre N; Chen Y; Wildey G; Dowlati A
    Mol Oncol; 2018 Dec; 12(12):2124-2135. PubMed ID: 30259640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy.
    Yang SF; Hou MF; Chen FM; Ou-Yang F; Wu YC; Chai CY; Yeh YT
    BMC Cancer; 2016 Jan; 16():20. PubMed ID: 26768588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.
    Wu W; Takanashi M; Borjigin N; Ohno SI; Fujita K; Hoshino S; Osaka Y; Tsuchida A; Kuroda M
    Br J Cancer; 2013 Feb; 108(3):653-61. PubMed ID: 23322197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tunicamycin-induced ER stress regulates chemokine CCL5 expression and secretion via STAT3 followed by decreased transmigration of MCF-7 breast cancer cells.
    Zhang Y; Liao S; Fan W; Wei W; Wang C; Sun S
    Oncol Rep; 2014 Dec; 32(6):2769-76. PubMed ID: 25231320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
    Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
    Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
    Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
    J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of STAT3 NH
    Ray S; Coulter DW; Gray SD; Sughroue JA; Roychoudhury S; McIntyre EM; Chaturvedi NK; Bhakat KK; Joshi SS; McGuire TR; Sharp JG
    Mol Carcinog; 2018 Apr; 57(4):536-548. PubMed ID: 29280516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
    Gan L; Yin ZF; Li M
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.
    Jiao J; Zhang R; Li Z; Yin Y; Fang X; Ding X; Cai Y; Yang S; Mu H; Zong D; Chen Y; Zhang Y; Zou J; Shao J; Huang Z
    Nat Commun; 2018 Jun; 9(1):2504. PubMed ID: 29950561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
    Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
    Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells.
    Yi EH; Lee CS; Lee JK; Lee YJ; Shin MK; Cho CH; Kang KW; Lee JW; Han W; Noh DY; Kim YN; Cho IH; Ye SK
    Mol Cancer Res; 2013 Jan; 11(1):31-42. PubMed ID: 23074171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down regulation of CD24 and HER-2/neu in breast carcinoma cells by activated human dendritic cell. Role of STAT3.
    Hira SK; Manna PP
    Cell Immunol; 2012; 275(1-2):69-79. PubMed ID: 22480875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.